Melatonin FOB New York quotations increased in mid-March 2026, driven by tightened near-term availability and accelerated retail call-offs. Early March trading consolidated following post-holiday flows, but the growing sensitivity to Middle East energy and logistics disruptions prompted buyers to secure allocations, adding support to offers. Inventories at New York export warehouses remained balanced, although import detention risks and promotional-driven call-offs heightened market tensions. Demand patterns varied across end markets, with strong support from nutraceuticals and retail channels. Gummy formulations dominated sales, particularly among Millennials and Gen Z consumers. Conversely, private-label and some domestic formulators adopted just-in-time purchasing strategies, reducing urgency for new spot orders. Despite stable upstream feedstock availability, tightening logistics and regulatory challenges arose from the ongoing conflict in the Middle East. Looking ahead, analysis indicates potential for continued upward trends driven by constrained imports and sustained demand, although seasonal and geopolitical factors will influence future price fluctuations and supply stability.
The export market of Melatonin in the US has increased FOB New York quotations in mid-March 2026 with prices rising 1.08% in the mid-month assessment as near-term availability tightened and retail call-offs accelerated. Early March trading had largely consolidated following post-holiday flows; however, the heightened sensitivity to Middle East energy and logistics volatility has compelled the Melatonin procurers to secure allocations which supported the firm FOB offers. The Melatonin inventories at New York export warehouses remained at a typical two-to-three-week level, indicating balanced on-hand supply even as import detention risks and promotional-driven call-offs elevated near-term tensions in the melatonin market, according to weekly assessment data.
The demand dynamics of Melatonin were mixed across the different end-user markets which cushioned the overall uptick. The nutraceuticals and retail channels were supportive with gummies dominating online unit sales. The promotions has successfully drawn the Melatonin consumers and syndicated data showed unit sales up 3% year-on-year with gummies representing a substantial share. In contrast, private-label and some domestic formulators have adopted just-in-time buying and drew down inventories after February restocking which tempered the urgency for new spot purchases. Meanwhile, export buyers of Melatonin have maintained normal contract volumes to Canada, Mexico and European formulators which resulted in steadier offtake rather than significant spot inquiries.
ChemAnalyst analysed the Melatonin supply dynamics and noted that the upstream feedstock availability and plant operating patterns were largely neutral which supported the steady conversion margins for melatonin production. L-tryptophan procurement across trans-Pacific contracts were attainable, while natural-gas-linked steam costs traded within a stable range in the Northeast that allowed the US reactors to operate near routine loads without reported outages or scheduled maintenance. However, logistics and regulatory drivers have tightened due to ongoing conflict with Iran which resulted in increased logistical hurdles. The rising energy and shipping pressures linked to the Middle East conflict has raised short-term scarcity risks which underpinned higher melatonin quotations.
ChemAnalyst analysis points to continued upside in the near term which is driven by constrained imports and persistent retail & export demand prompting earlier shipments and inventory replenishment. Ongoing geopolitical tensions in the Middle East are expected to exacerbate logistics and energy costs which will further impact melatonin supply chains. Current projections suggest stronger increase in melatonin prices into March and April, although some easing may occur later in the spring. The seasonal factors like the post-holiday inventory drawdown and any escalation in energy or logistics disruptions due to geopolitical developments will be crucial in determining whether the melatonin prices will extend gains or stabilize ahead of summer. The melatonin market is navigating a complex landscape. The balanced robust demand against a backdrop of geopolitical uncertainty can influence both prices and availability of melatonin in the upcoming period.
